Table 3

Monthly quantity and market share of fixed-dose combination of cholesterol-lowering drugs in 2012 and 2015

Drug20122015P value
Linicor (lovastatin 20 mg + niacin ER 500 mg)/tablet, tablets/month (%)5024.0±5162.0 (9.52)0.006
Vytorin (ezetimibe 10 mg + simvastatin 10 mg)/tablet, tablets/month (%)590.6±111.0 (1.31)251.3±77.0 (0.48)<0.001
Vytorin (ezetimibe 10 mg + simvastatin 20 mg)/tablet, tablets/month (%)27 136.0±3047.0 (60.24)33 090.0±4139.0 (62.71)0.001
Caduet 5/10 (amlodipine 5 mg + atorvastatin 10 mg)/tablet, tablets/month (%)17 316.9±2349.2 (38.44)14 404.8±1228.9 (27.30)0.001
  • Mean±SD represents the number of patients receiving a given drug each year.